Novavax on Friday said it had struck a licensing deal worth at least $1.2 billion with Sanofi for its COVID-19 vaccine in ...
The deal will allow Novavax to lift its "going concern" warning, which it first issued in 2023 due to having "substantial ...
Shah Capital Management has withdrawn a proxy campaign against the re-election of directors at vaccines firm Novavax in the ...
Novavax (NVAX) stock surged after reaching a licensing agreement with Sanofi (SNY) for its COVID-19 vaccine and Matrix-M adjuvant. Read more here.
Novavax (NVAX) partners with Sanofi to market its COVID-19 vaccine and also develop novel COVID-19-influenza combination ...
Novavax will only be able to offer a COVID-19 vaccine in the United States this autumn if regulators accept the shot it has ...
Novavax will only be able to offer a COVID-19 vaccine in the United States this autumn if regulators accept the shot it has ...
The COVID-19 vaccine was worth tens of billions of dollars, but most of it went into the hands of Moderna and Pfizer. Smaller ...
Shares of vaccine stocks Moderna ( MRNA 1.58%), Novavax ( NVAX 2.31%), and BioNTech SE ( BNTX -2.07%) rallied this week, ...
In the stock market, a back-from-the-dead story is equally appealing. Stocks that have been left for dead, or at least seen ...
Detailed price information for Catalyst Pharm Inc (CPRX-Q) from The Globe and Mail including charting and trades.
A Hong Kong court has ruled in favor of creditors in cases involving a controversial credit protection mechanism popular ...